Galantamine    (DrugBank: Galantamine)

2 diseases
IDDisease name (Link within this page)Number of trials
6Parkinson disease2
127Frontotemporal lobar degeneration1

6. Parkinson disease    [ 2,123 clinical trials,   2,046 drugs,   (DrugBank: 324 drugs),   183 drug target genes,   198 drug target pathways]
Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 2,123 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2008-006278-13-NL
(EUCTR)
04/02/200915/10/2008Motor function optimization in advanced Parkinson’s disease patients, combined with galantamine to prevent visual hallucinations.Motor function optimization in advanced Parkinson’s disease patients, combined with galantamine to prevent visual hallucinations. patients with advanced (>5 years) Parkinson's disease and visual hallucinations.
MedDRA version: 9.1;Level: LLT;Classification code 10047570;Term: Visual hallucinations
MedDRA version: 9.1;Classification code 10013113;Term: Disease Parkinson's
Trade Name: Reminyl Retard
Trade Name: Sinemet 125 mg
UMCGNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
10Netherlands
2NCT00211588
(ClinicalTrials.gov)
June 200413/9/2005Galantamine Executive Function in Parkinson's DiseaseInvestigator Initiated Study: Galantamine CR Potential Enhancement of Attentional and Executive Function in Non-Demented Patients With Parkinson's DiseaseParkinson's DiseaseDrug: galantamineMemorial Hospital of Rhode IslandOrtho-McNeil Neurologics, Inc.Active, not recruiting60 Years85 YearsBoth90N/AUnited States

127. Frontotemporal lobar degeneration    [ 74 clinical trials,   83 drugs,   (DrugBank: 28 drugs),   29 drug target genes,   99 drug target pathways]
Searched query = "Frontotemporal lobar degeneration", "Frontotemporal dementia", "Semantic dementia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 74 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00416169
(ClinicalTrials.gov)
May 200322/12/2006A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal DementiaAn Open Pilot Study to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Pick's Disease/Frontotemporal Dementia /Pick ComplexFrontotemporal Dementia;Pick ComplexDrug: galantamine hydrobromideJohnson & Johnson Pharmaceutical Research & Development, L.L.C.NULLCompleted30 Years80 YearsBoth41Phase 2NULL